Reginald Low is a nationally recognized clinical investigator in cardiology who incorporates the best of leading-edge technology with the highest quality of patient care. His research focuses on coronary artery disease and developing minimally invasive methods of diagnosis and treatment.
M.D., UC Davis School of Medicine, Sacramento, California, 1975
B.A., UCLA, Los Angeles, California, 1969
Internship: University of California, Davis Medical Center, Sacramento, California, 1975-76
University of California, Davis Medical Center, Sacramento, California, 1976-78
University of California, Davis Medical Center, Sacramento, California, 1978-80
American Board of Internal Medicine, 1978
American Board of Internal Medicine, Cardiovascular Medicine, 1981
American College of Angiology
American College of Cardiology
American College of Chest Physicians
American College of Laser Medicine and Surgery
American Heart Association
Sacramento-El Dorado County Medical Society
Select Recent Publications
Treede H, Tubler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, Mueller R, Low R, Bolling SF, Meinertz T, Schofer J. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J Thorac Cardiovasc Surg 2010 Oct;140(4):897-903.
feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D, for the EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (endovascular Valve Edge-to-Edge REpair Study) cohort. Journal of the American College of Cardiology 2009; 54:686-694.
Li N, liu JY, Timofeyev V, Qiu H, Hwang SH, Tuteja D, Lu L, Yang J, Mochida H, Low R, Hammock BD, Chiamvimonvat N. Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. J Mol Cell Cardiol 2009 Dec;47(6):835-45.
Rogers JH, Rahdert DA, Caputo GR, Takeda PA, Palacios IF, Tio FO, Taylor EA, Low RI. Long-term safety and durability of percutaneous septal sinus shortening (The PS2 System) in an ovine model. Catheterization and Cardiovascular Interventions 2009; 73:540-548.
Taneja M, Tay KH, sebastian M, Pasupathy S, Lin SE, Teo T, Low R, Irani FG, Chng SP, Dewan A, Tan BS. Self-expanding nitinol stents in recanalisation of long-length superficial femoral artery occlusions in patients with critical limb ischaemia. Singapore Med J 2009 Dec;50(12):1184-8.
Low RI, Bolling SF, Yeo KK, Ebner A. Direct flow medical percutaneous aortic valve: proof of concept. EuroIntervetion 2008;4(2):256-261.
Fellmeth, B.D., Baron, S.B., Brown, P.R., Ang, J.G., Clayson, K.R., Morrison, S.L., Low, R. Repair of postcatheterization femoral pseudoaneurysms by color flow ultrasound guided compression AHJ 1992 Feb;123(2)547-51
Lee, G., Reis, R.L., Boggan, M.D., Chan, M.C., Lee, M.H., Low, R., Hannah, H. 3d, Mason, C.T. Laser recanalization in severe end-stage peripheral vascular disease American Journal of Cardiology 1987 Feb 1;59(4):386-7
Low, R., Takeda, P., Lee, G., Mason, D.T. Potential efficacy of calcium antagonists and heparin in patients with embolic strokes American Heart Journal 1986 Dec; 112(6)1338-9
Lee, G., Ikeda, R.M., Chan, M.C., Lee, M.H., Rink, J.I., Reis, R.L. Theis, J.H., Low, R., Bommer, W.J., Kung, A.H., et al. Limitations, risks and complications of laser recanalization: a cautious approach warranted. American Journal of Cardiology 1985; Ju